Krsnaa Diagnostics has entered into a strategic collaboration with AZmed, a global radiology AI innovator, to improve diagnostic services using advanced artificial intelligence technology. This partnership focuses on leveraging AZmed’s AI suite to enhance operational efficiency and support growth across Krsnaa’s extensive network.
- Krsnaa Diagnostics operates in 19 states and union territories through a public-private partnership model.
- The company has over 190 CT scan centres, 2700 X-ray centres, and 212 pathology laboratories.
- AZmed’s AZtrauma solution, part of the Rayvolve AI suite, will be evaluated for detecting fractures, joint effusions, and dislocations on X-rays.
- AZmed’s Rayvolve was the first AI software to receive CE marking for fracture detection in X-rays in 2019.
- Krsnaa Diagnostics aims to improve productivity, expand reporting capacity, and build a scalable operating model with AI integration.
What is the significance of Krsnaa Diagnostics' collaboration with AZmed?
The collaboration allows Krsnaa Diagnostics to integrate AZmed’s advanced AI technology into its radiology services. This integration is expected to improve the detection and triage of fractures and other conditions on X-rays, leading to faster and more accurate diagnoses.
How extensive is Krsnaa Diagnostics' network?
Krsnaa Diagnostics operates in 19 states and union territories in India. It has a vast network that includes more than 190 CT scan centres, over 2700 X-ray centres, and 212 pathology laboratories. This wide reach enables the company to serve a large number of patients across the country.
What is AZmed’s AZtrauma solution?
AZtrauma is part of AZmed’s Rayvolve AI suite, designed specifically for radiology applications. It helps detect and triage fractures, joint effusions, and dislocations on X-ray images. The solution was the first AI software to receive CE marking for fracture detection in X-rays in 2019, highlighting its reliability and effectiveness.
What benefits does Krsnaa Diagnostics expect from this AI collaboration?
By incorporating AZmed’s AI technology, Krsnaa Diagnostics aims to unlock operating leverage and enhance productivity. The company plans to expand its reporting capacity and create a more scalable operating model. This will enable Krsnaa to serve more patients efficiently while maintaining affordable pricing.
How have Krsnaa Diagnostics’ shares performed recently?
In 2026, Krsnaa Diagnostics’ shares have experienced a decline. Year-to-date, the shares have dropped by 31%, and over the trailing twelve months, they have fallen by 37%. In the short term, the shares decreased by 8.6% on a monthly basis, reflecting broader market pessimism.
Frequently Asked Questions
Q: What services does Krsnaa Diagnostics provide?
A: Krsnaa Diagnostics offers diagnostics, pathology, and teleradiology services across multiple states in India through a public-private partnership model.
Q: What is the goal of the collaboration with AZmed?
A: The goal is to use AZmed’s AI technology to improve the accuracy and efficiency of radiology diagnostics, particularly in detecting fractures and related conditions on X-rays.
Q: How does AI improve diagnostic services?
A: AI can analyze medical images quickly and accurately, helping radiologists detect abnormalities earlier and reduce human error, leading to better patient outcomes.
Q: What is the significance of CE marking for AZmed’s AI software?
A: CE marking indicates that the AI software meets European health, safety, and environmental protection standards, confirming its reliability for clinical use.
